CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-22 | Brazzell Romulus K SEE REMARKS | Grant or award | +49,356 | 85,808 | ||
| 2023-06-22 | Brazzell Romulus K SEE REMARKS | Grant or award · Stock Option (right to buy) | +65,808 | 65,808 | ||
| 2023-06-22 | Bazemore Todd SEE REMARKS | Grant or award | +48,698 | 84,691 | ||
| 2023-06-22 | Bazemore Todd SEE REMARKS | Grant or award · Stock Option (right to buy) | +64,931 | 64,931 | ||
| 2023-06-22 | Blumenkranz Mark S. Director | Grant or award | +3,784 | 10,591 | ||
| 2023-06-22 | Blumenkranz Mark S. Director | Grant or award | +1,100 | 11,691 | ||
| 2023-06-22 | Blumenkranz Mark S. Director | Grant or award · Stock Option (right to buy) | +5,046 | 5,046 | ||
| 2023-06-22 | Blumenkranz Mark S. Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2023-06-22 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +158,873 | 276,554 | ||
| 2023-06-22 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +211,831 | 211,831 | ||
| 2023-05-31 | Rosen Howard B Director | Grant or award | +2,502 | 3,399 | ||
| 2023-05-31 | Rosen Howard B Director | Returned to the company · Stock Option (right to buy) | −764 | 0 | ||
| 2023-05-31 | Rosen Howard B Director | Returned to the company · Stock Option (right to buy) | −259 | 0 | ||
| 2023-05-31 | Rosen Howard B Director | Returned to the company · Stock Option (right to buy) | −259 | 0 | ||
| 2023-05-31 | Rosen Howard B Director | Returned to the company · Stock Option (right to buy) | −420 | 0 | ||
| 2023-05-31 | Rosen Howard B Director | Returned to the company · Stock Option (right to buy) | −800 | 0 | ||
| 2023-05-31 | Farid Marjan Director | Grant or award | +1,600 | 1,600 | ||
| 2023-05-31 | Farid Marjan Director | Returned to the company · Stock Option (right to buy) | −1,600 | 0 | ||
| 2023-05-31 | PERRY GREGORY D Director | Grant or award | +1,738 | 2,538 | ||
| 2023-05-31 | PERRY GREGORY D Director | Returned to the company · Stock Option (right to buy) | −518 | 0 |
Page 7 of 12 · 236 trades